TN2013000430A1 - Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) - Google Patents
Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)Info
- Publication number
- TN2013000430A1 TN2013000430A1 TNP2013000430A TN2013000430A TN2013000430A1 TN 2013000430 A1 TN2013000430 A1 TN 2013000430A1 TN P2013000430 A TNP2013000430 A TN P2013000430A TN 2013000430 A TN2013000430 A TN 2013000430A TN 2013000430 A1 TN2013000430 A1 TN 2013000430A1
- Authority
- TN
- Tunisia
- Prior art keywords
- irinocetan
- folfiri
- aflibercept
- fluorouracil
- composition
- Prior art date
Links
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002949 fluorouracil Drugs 0.000 title abstract 3
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 title abstract 2
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002833 aflibercept Drugs 0.000 title abstract 2
- 108010081667 aflibercept Proteins 0.000 title abstract 2
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 title abstract 2
- 235000008191 folinic acid Nutrition 0.000 title abstract 2
- 239000011672 folinic acid Substances 0.000 title abstract 2
- 229960001691 leucovorin Drugs 0.000 title abstract 2
- 206010009944 Colon cancer Diseases 0.000 abstract 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinocetan (FOLFIRI) useful in the treatment of Colorectal cancer (CRC).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306154 | 2011-09-15 | ||
| PCT/EP2012/057542 WO2012146610A1 (en) | 2011-04-26 | 2012-04-25 | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000430A1 true TN2013000430A1 (en) | 2015-03-30 |
Family
ID=54359587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000430A TN2013000430A1 (en) | 2011-09-15 | 2013-10-18 | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000430A1 (en) |
-
2013
- 2013-10-18 TN TNP2013000430A patent/TN2013000430A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013502195A1 (en) | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) | |
| GB201106750D0 (en) | Novel compounds | |
| GB201106743D0 (en) | Novel compounds | |
| NZ602385A (en) | Methods of treating cancer | |
| EP4582090A3 (en) | Composition comprising pegylated arginine deiminase | |
| PL3517539T3 (en) | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes | |
| IN2015KN00005A (en) | ||
| MX2016004678A (en) | Methods and compositions for treating cancer. | |
| PH12015501088A1 (en) | Dimeric compounds | |
| NZ606589A (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof | |
| MX2014012477A (en) | Pyrrolopyrazone inhibitors of tankyrase. | |
| MY161601A (en) | Films and compositions comprising the same | |
| IL224766A (en) | Bard1 isoforms in lung and colorectal cancer and use thereof | |
| PH12015500185B1 (en) | Azaheterocycles as bir2 and/or bir3 inhibitors | |
| MY163067A (en) | Peg or peg block copolymers for treating colorectal cancer | |
| PL2754441T3 (en) | Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives | |
| TN2013000430A1 (en) | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) | |
| MX2013009456A (en) | Vinyl -aryl - sulfones for use in peritoneal carcinomatosis. | |
| GB201004677D0 (en) | New salt | |
| 강신욱 | Issues and Prospect of the Basic Social Security in 2012 | |
| TN2013000173A1 (en) | Peg or peg block copolymers for treating colorectal cancer | |
| TN2013000404A1 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
| NZ725567A (en) | R-spondin translocations and methods using the same | |
| WO2013176667A3 (en) | Maspin-based treatment and prevention of cancer |